More precisely, expression levels of both ER and PgR, tumor grading, and overexpression of the human epidermal growth factor receptor 2 (HER2) reached levels of agreement equal to 55%, 58%, and 64%, respectively (Table 1, items 1.d, 1.e, and 1.f). This evidence concerns the gene ERBB2 and neoplasm.